| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
5,867 |
5,082 |
$458K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
4,658 |
3,973 |
$226K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
1,542 |
1,200 |
$118K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
683 |
578 |
$97K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
1,206 |
1,039 |
$90K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
884 |
770 |
$72K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
862 |
642 |
$59K |
| 96127 |
|
1,360 |
1,178 |
$24K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
950 |
892 |
$22K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
1,140 |
952 |
$18K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
451 |
320 |
$16K |
| 96160 |
|
933 |
693 |
$14K |
| 92551 |
|
882 |
757 |
$13K |
| 90686 |
|
1,175 |
1,025 |
$12K |
| D1206 |
Topical application of fluoride varnish |
316 |
252 |
$8K |
| 90698 |
|
498 |
379 |
$6K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
285 |
198 |
$6K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
323 |
296 |
$5K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
100 |
89 |
$4K |
| 90674 |
|
255 |
208 |
$4K |
| 99173 |
|
526 |
481 |
$4K |
| 90651 |
|
180 |
139 |
$4K |
| 90671 |
|
152 |
95 |
$3K |
| 90670 |
|
201 |
193 |
$3K |
| 83655 |
|
219 |
180 |
$3K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
48 |
34 |
$2K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
59 |
55 |
$2K |
| 85018 |
|
858 |
706 |
$2K |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
124 |
107 |
$2K |
| 99174 |
|
169 |
130 |
$1K |
| 90680 |
|
85 |
65 |
$1K |
| 90619 |
|
70 |
44 |
$1K |
| 90734 |
|
106 |
86 |
$985.60 |
| 36416 |
|
240 |
200 |
$981.00 |
| 90661 |
|
40 |
39 |
$668.40 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
48 |
48 |
$618.24 |
| 83718 |
|
77 |
59 |
$610.38 |
| 90633 |
|
30 |
26 |
$320.98 |
| 82465 |
|
71 |
59 |
$301.04 |
| 90656 |
|
13 |
12 |
$217.23 |
| 90700 |
|
15 |
13 |
$188.40 |
| 90744 |
|
28 |
27 |
$172.80 |